Lupin acquires Huminsulin from Lilly to enhance diabetes portfolio
The huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and childre
The huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and childre
Afrezza, developed by MannKind Corporation in the USA, offers a needle-free, rapid-acting insulin option for diabetes management
Lupin's R&D teams are working on products with a near-zero global warming potential propellant
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
Agreement further expands Aptar Pharma’s leading respiratory portfolio
The partnership marks a significant milestone in integrating digital health education into medical curricula
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Subscribe To Our Newsletter & Stay Updated